1. Home
  2. BOLT vs GORV Comparison

BOLT vs GORV Comparison

Compare BOLT & GORV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BOLT
  • GORV
  • Stock Information
  • Founded
  • BOLT 2015
  • GORV 1976
  • Country
  • BOLT United States
  • GORV United States
  • Employees
  • BOLT N/A
  • GORV N/A
  • Industry
  • BOLT Biotechnology: Pharmaceutical Preparations
  • GORV Retail-Auto Dealers and Gas Stations
  • Sector
  • BOLT Health Care
  • GORV Consumer Discretionary
  • Exchange
  • BOLT Nasdaq
  • GORV Nasdaq
  • Market Cap
  • BOLT 9.4M
  • GORV 10.6M
  • IPO Year
  • BOLT 2021
  • GORV 2015
  • Fundamental
  • Price
  • BOLT $5.32
  • GORV $2.45
  • Analyst Decision
  • BOLT Buy
  • GORV
  • Analyst Count
  • BOLT 3
  • GORV 0
  • Target Price
  • BOLT $47.50
  • GORV N/A
  • AVG Volume (30 Days)
  • BOLT 10.9K
  • GORV 65.2K
  • Earning Date
  • BOLT 11-11-2025
  • GORV 08-14-2025
  • Dividend Yield
  • BOLT N/A
  • GORV N/A
  • EPS Growth
  • BOLT N/A
  • GORV N/A
  • EPS
  • BOLT N/A
  • GORV N/A
  • Revenue
  • BOLT $4,167,000.00
  • GORV $662,952,000.00
  • Revenue This Year
  • BOLT N/A
  • GORV $15.65
  • Revenue Next Year
  • BOLT N/A
  • GORV $20.54
  • P/E Ratio
  • BOLT N/A
  • GORV N/A
  • Revenue Growth
  • BOLT N/A
  • GORV N/A
  • 52 Week Low
  • BOLT $4.59
  • GORV $2.22
  • 52 Week High
  • BOLT $14.36
  • GORV $58.80
  • Technical
  • Relative Strength Index (RSI)
  • BOLT 51.15
  • GORV 28.67
  • Support Level
  • BOLT $5.00
  • GORV $2.22
  • Resistance Level
  • BOLT $5.50
  • GORV $2.89
  • Average True Range (ATR)
  • BOLT 0.22
  • GORV 0.31
  • MACD
  • BOLT 0.05
  • GORV 0.03
  • Stochastic Oscillator
  • BOLT 74.06
  • GORV 12.81

About BOLT Bolt Biotherapeutics Inc.

Bolt Biotherapeutics Inc is a clinical-stage immuno-oncology company. It is developing tumor-targeted therapies that leverage the power of the innate and adaptive immune systems. The company's pipeline candidates are built on deep expertise in myeloid biology and cancer drug development. The company's proprietary Boltbody ISAC platform technology combines tumor-targeting antibodies with immune-stimulating linker-payloads. The company's pipeline consists of BDC-1001, BDC-3042, and Next-Gen ISAC.

About GORV Lazydays Holdings Inc.

Lazydays Holdings Inc operates recreational vehicle dealerships. It provides products and services for RV owners and outdoor enthusiasts. The company generates revenue by providing a full spectrum of RV products: New and pre-owned RV sales, RV parts and services, financing and insurance products, third-party protection plans, after-market parts and accessories, and RV camping facilities.

Share on Social Networks: